Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma
Paolo Andrea Zucali(Humanitas University), Armando Santoro(IRCCS Humanitas Research Hospital), Giovanni Luca Ceresoli(Humanitas Gavazzeni), Fabio De Vincenzo(Humanitas University), Matteo Simonelli(Humanitas University), Elena Lorenzi(Humanitas University), Matteo Perrino(IRCCS Humanitas Research Hospital), Laura Giordano(Istituti di Ricovero e Cura a Carattere Scientifico), Letizia Gianoncelli(Humanitas University), Rita De Sanctis(Humanitas University)
Cited by 58
Related Papers
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
|JAMA|2014|569
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532